Is ARYX or MCD a better dividend investment in 2026?

ARYX currently yields 400000.00% with a 5% 5-year dividend growth rate. MCD yields 2.35% with 8.5% growth. The better choice depends on your goal: ARYX offers higher current income.

What is the dividend yield difference between ARYX and MCD?

ARYX has a forward dividend yield of 400000.00% ($2.00/share annually). MCD yields 2.35% ($7.26/share annually). The yield gap is 399997.65 percentage points.

Home › Compare › ARYX vs MCD

ARYX vs MCD: Dividend Comparison 2026

ARYX yields 400000.00% · MCD yields 2.35%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARYX wins by $5.011119029548644e+32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARYX

● Live price

400000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.011119029548644e+32M

Annual income

$500,865,583,351,836,840,000,000,000,000,000,000,000.00

Full ARYX calculator →

MCD

McDonald's Corporation

● Live price

2.35%

Share price

$308.53

Annual div

$7.26

5Y div CAGR

42.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$78.5K

Annual income

$26,227.70

Full MCD calculator →

Portfolio growth — ARYX vs MCD

📍 ARYX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARYX	MCD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARYX + MCD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARYX pays

MCD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARYX

Annual income on $10K today (after 15% tax)

$34,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr

MCD

Annual income on $10K today (after 15% tax)

$200.01/yr

After 10yr DRIP, annual income (after tax)

$22,293.55/yr

At 15% tax rate, ARYX beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARYX + MCD for your $10,000?

ARYX: 50%MCD: 50%

100% MCD50/50100% ARYX

Portfolio after 10yr

$2.505559514774322e+32M

Annual income

$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr

Blended yield

99.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

ARYX

No analyst data

Altman Z

-56.9

Piotroski

1/9

MCD

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$351.76

+14.0% upside vs current

Range: $320.00 — $385.00

Altman Z

4.9

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARYX buys

MCD buys

No recent congressional trades found for ARYX or MCD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARYXMCD

Forward yield	400000.00% ✓	2.35%
Annual dividend / share	$2.00	$7.26 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	42.3% ✓
Portfolio after 10y	$5.011119029548644e+32M	$78.5K ✓
Annual income after 10y	$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓	$26,227.70
Total dividends collected	$5.010957816668433e+32M	$58.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: ARYX vs MCD ($10,000, DRIP)

Year	ARYX Portfolio	ARYX Income/yr	MCD Portfolio	MCD Income/yr	Gap
1← crossover	$40,010,700	$40,000,000.00	$10,815	$334.85	+$40.00M → ARYX
2	$149,615,521,729	$149,572,710,280.37	$11,826	$491.71	+$149615.51M → ARYX
3	$522,880,052,725,200	$522,719,964,116,949.25	$13,123	$730.06	+$522880052.71M → ARYX
4	$1,707,862,989,289,045,000	$1,707,303,507,632,628,700.00	$14,853	$1,100.07	+$1707862989289.03M → ARYX
5	$5,213,509,402,845,684,000,000	$5,211,681,989,447,144,000,000.00	$17,257	$1,690.61	+$5213509402845684.00M → ARYX
6	$14,874,219,058,409,543,000,000,000	$14,868,640,603,348,497,000,000,000.00	$20,752	$2,667.01	+$14874219058409543680.00M → ARYX
7	$39,661,196,234,050,755,000,000,000,000	$39,645,280,819,658,260,000,000,000,000.00	$26,103	$4,354.83	+$3.966119623405075e+22M → ARYX
8	$98,838,436,350,327,300,000,000,000,000,000	$98,795,998,870,356,880,000,000,000,000,000.00	$34,794	$7,437.78	+$9.88384363503273e+25M → ARYX
9	$230,205,236,474,344,900,000,000,000,000,000,000	$230,099,479,347,450,050,000,000,000,000,000,000.00	$49,926	$13,461.60	+$2.302052364743449e+29M → ARYX
10	$501,111,902,954,864,400,000,000,000,000,000,000,000	$500,865,583,351,836,840,000,000,000,000,000,000,000.00	$78,550	$26,227.70	+$5.011119029548644e+32M → ARYX

ARYX vs MCD: Complete Analysis 2026

ARYX — Stock

ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company's other clinical development products comprise ATI-7505, an oral prokinetic agent, which is in Phase IIb clinical development for the treatment of chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease; and ATI-9242, an antipsychotic agent in Phase I clinical development for the treatment of schizophrenia and other psychiatric disorders. It also focuses on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal disorders that are in discovery stage. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California.

Full ARYX Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →

📬

Get this ARYX vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARYX vs SCHD ARYX vs JEPI ARYX vs O ARYX vs KO ARYX vs MAIN ARYX vs YUM ARYX vs QSR ARYX vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.